Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Operable Breast Cancer”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Not applicableUnknownNCT00502684
What this trial is testing

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Who this might be right for
Primary Operable Breast Cancer
Kaplan Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Testing effectiveness (Phase 2)Study completedNCT01779479
What this trial is testing

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 333
Large-scale testing (Phase 3)Study completedNCT03969121
What this trial is testing

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Who this might be right for
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Kyoto Breast Cancer Research Network 141
Not applicableLooking for participantsNCT06830590
What this trial is testing

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Who this might be right for
Breast CancerMolecular Pathway DeregulationTreatment
Liaquat University of Medical & Health Sciences 300
Testing effectiveness (Phase 2)Study completedNCT03395899
What this trial is testing

Pre-operative Immunotherapy Combination Strategies in Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
Queen Mary University of London 71
Large-scale testing (Phase 3)Ended earlyNCT00010153
What this trial is testing

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00003013
What this trial is testing

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 450
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Testing effectiveness (Phase 2)WithdrawnNCT00434031
What this trial is testing

CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples
Large-scale testing (Phase 3)Study completedNCT00123669
What this trial is testing

Primary Progesterone Therapy for Operable Breast Cancer

Who this might be right for
Breast Neoplasms
Tata Memorial Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Testing effectiveness (Phase 2)Study completedNCT02488564
What this trial is testing

Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 49
Testing effectiveness (Phase 2)Study completedNCT00239343
What this trial is testing

Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 160
Testing effectiveness (Phase 2)Study completedNCT00256360
What this trial is testing

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 117
Large-scale testing (Phase 3)Study completedNCT00544765
What this trial is testing

Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 2,014
Early research (Phase 1)Study completedNCT00008034
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Load More Results